In Partnership with:
56 Stories, most recent news story added 21 minutes ago
Forty people underwent precautionary decontamination last night after a suspicious white powder was mailed to the Midtown diplomatic outposts of three countries. There were no reported injuries in what officials suspect was an elaborate hoax. The ...
Letters containing a mysterious white powder were received Monday at the UN missions of France and Austria and the Consulate General of Uzbekistan - triggering a huge emergency response, officials said.
Envelopes containing suspicious powder were sent to three foreign consulates in Manhattan on Monday, but initial tests suggested the mailings were a hoax, police officials said.
French, Austrian, Uzbekistan Offices Receive Envelopes; Anthrax Test Negative; Letters Postmarked from Dallas
A suspicious white powder was sent to three countries' missions or consulates in Manhattan. READ MORE >>
Envelopes containing suspicious powder were sent to three foreign consulates in Manhattan, but initial tests suggested the mailings were a hoax, police officials said. Units respond in midtown/ Daily News | AUDIO
But initial tests are negative for Anthrax or any other dangerous substance
Authorities are investigating some suspicious letters containing white powder that were sent to three foreign-government missions to the United Nations in Manhattan. Letters arrived at the missions of Uzbekistan, Austria, and France Monday, police said.
New York - A suspicious white powder contained in envelopes sent to the missions of France, Austria and Uzbekistan in New York were determined to be harmless after laboratory tests, news reports said Tuesday. The discovery of the envelopes at the thr...
NEW YORK -- Envelopes containing suspicious powder were sent to three foreign consulates in Manhattan on Monday, but initial tests suggested the mailings were a hoax, police officials said. A field test done on the powder sent the Uzbekistan Consulate came...
Advanced Life Sciences Holdings, Inc. , a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the third quarter ended September 30, 2009.
ALISO VIEJO, Calif.----AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ in the treatment of patients with pseudobulbar affect .
The fall of the Berlin Wall, 9/11 and the collapse of Lehman Brothers: Each ushered in a new American era
Please, heed this warning: The swine flu vaccine is dangerous and can be deadly. I am writing this letter to inform the public about the dangers of this vaccine. I care for the well-being of everyone. I have been...
For three weeks in 2002 John Allen Muhammad led a two-man sniper team that struck on his orders, claimed 10 lives and deliberately terrorized Virginia, Maryland and Washington.
Bon Jovi - The Circle From its single "We Weren't Born To Follow" through its closer "Learn To Love," The Circle doesn't overextend or pretend...